ASPEN Pharmacare, in consultaion with the Therapeutic Goods Administration, has initiated a recall for product correction of its Span-K (potassium chloride) 600mg tablets.
The TGA advised it had been identified that bottles of the medicine had been provided without child-resistant caps.
Aspen Australia has launched the recall to replace all caps on bottles of Span-K 600mg tablets regardless of batch number or expiry date.
The TGA noted there was no concern regarding the quality or safety of the medicine itself, other than the absence of child-resistant packaging.
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Apr 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Apr 17
